• a summary of method validation and verification studies for all analytical methods used for product release;
• a summary of the impact assessment for released batches;
• improved procedures regarding validation/verification requirements and updated analytical methods;
• a comprehensive, independent review of your laboratory practices, methods, equipment, and analyst competencies. Based on this review, provide a detailed corrective action and preventive action (CAPA) plan to fully remediate your laboratory system.
• a global CAPA plan as requested below under “Data Integrity Remediation.”
• provide a summary of your interim controls to prevent deletion and modification of data;
• define the roles and responsibilities of personnel who have access to analytical instruments and data;
• provide a standard operating procedure (SOP) that ensures that all quality control tests are performed by an analyst and receive second-tier review (e.g., by a manager) from a separate individual;
• detail the associated user privileges for each analytical system;
• provide a detailed summary of your procedural updates and associated training for user role assignment and controls; and
• provide detailed procedures for your review of audit trail data.
• scientific rationale for API, rinse, and swab sample specifications prior to performing cleaning validation;
• a summary of updates to your cleaning validation protocol to better incorporate conditions identified as worst case. This should include evaluating drugs that are of highest toxicity, drugs that are lowest solubility in their cleaning solvents, and swabbing of various equipment locations that are most difficult to clean.
• a summary of SOP that have been updated to ensure an appropriate program for verification and validation of cleaning procedures for new products, processes, and equipment.